ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs MXN
17.12535
-0.16%
Brent Oil
85.245
-0.76%
Bitcoin
57,393.07
-5.29%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
01/05/202405:38GlobeNewswire Inc.Man Group PLC : Form 8.3 - Tyman plc
01/05/202405:37GlobeNewswire Inc.Form 8.3 - AXA INVESTMENT MANAGERS: Darktrace plc
01/05/202405:36Business WireATS To Host Fourth Quarter Earnings Call Thursday May 16, 2024, at 8:30 a.m. EasternNYSE:ATSATS Corporation
01/05/202405:33Edgar (US Regulatory)Form 8-K - Current reportNYSE:ABCAmerisourceBergen Corp
01/05/202405:30GlobeNewswire Inc.Aveanna to Participate at the RBC Capital Markets Global Healthcare ConferenceNASDAQ:AVAHAveanna Healthcare Holdings Inc
01/05/202405:30Alliance NewsAlliance NewsIreland unemployment rate rises to 4.4% in April from 4.1% in March
01/05/202405:30GlobeNewswire Inc.G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:GTHXG1 Therapeutics Inc
01/05/202405:30GlobeNewswire Inc.Bombardier to Confirm 2025 Objectives Are on Track and Will Further Detail Growth Levers Through 2030 as Part of Investor Day 2024BBD-B
01/05/202405:30GlobeNewswire Inc.Brookfield and Microsoft Collaborating to Deliver Over 10.5 GW of New Renewable Power Capacity GloballyNYSE:BAMBrookfield Asset Management Ltd
01/05/202405:30Business WireMetals Acquisition Limited Announces Appointment of Leanne Heywood to the Board of DirectorsNYSE:MTALMetals Acquisition Limited
01/05/202405:30GlobeNewswire Inc.Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual MeetingNYSE:TFXTeleflex Inc
01/05/202405:30Business WireWestlake Corporation Reports First Quarter 2024 ResultsNYSE:WLKWestlake Corporation
01/05/202405:30GlobeNewswire Inc.NxuOne™ Expands Subscription Charging ModelNASDAQ:NXUNXU Inc
01/05/202405:30GlobeNewswire Inc.Tower Semiconductor to Participate in the 52nd Annual JP Morgan Global Technology, Media, and Communications ConferenceNASDAQ:TSEMTower Semiconductor Ltd
01/05/202405:30Business WireUnited Therapeutics Corporation Reports First Quarter 2024 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
01/05/202405:30Business WireIDEXX Laboratories Announces First Quarter ResultsNASDAQ:IDXXIDEXX Laboratories Inc
01/05/202405:30Business WireESAB Corporation Announces First Quarter 2024 ResultsNYSE:ESABESAB Corporation
01/05/202405:30Business WireWolverine Worldwide Advances Strategic Transformation With New Licensing AgreementsNYSE:WWWWolverine World Wide Inc
01/05/202405:30GlobeNewswire Inc.Parsons Reports Strong First Quarter 2024 ResultsNYSE:PSNParsons Corporation
01/05/202405:30Business WireCencora Reports Fiscal 2024 Second Quarter ResultsNYSE:CORCencora Inc
01/05/202405:30Business WireJohnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” ReorganizationNYSE:JNJJohnson and Johnson
01/05/202405:30Business WireKalVista Pharmaceuticals Highlights Strategic Plans for Coming Fiscal YearNASDAQ:KALVKalVista Pharmaceuticals Inc
01/05/202405:30Business WireWestlake Chemical Partners LP Announces First Quarter 2024 ResultsNYSE:WLKPWestlake Chemical Partners LP
01/05/202405:30Business WireThe Estée Lauder Companies Inc. Declares Quarterly Dividend of $.66 Per ShareNYSE:ELEstee Lauder Companies Inc
01/05/202405:30PR Newswire (Canada)CGI reports second quarter Fiscal 2024 resultsNYSE:GIBCGI Inc
01/05/202405:30PR Newswire (US)BIO-TECHNE DECLARES DIVIDENDNASDAQ:TECHBio Techne Corporation
01/05/202405:30PR Newswire (Canada)Les résultats de Loblaw pour le premier trimestre de 2024 reflètent les efforts soutenus d'offrir de la valeur aux consommateurs tous les joursTSX:LLoblaw Companies Limited
01/05/202405:30PR Newswire (Canada)Uranium Energy Corp Applauds the U.S. Senate on Passing a Bipartisan Bill to Ban Russian Uranium Imports
01/05/202405:30PR Newswire (US)CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCENYSE:CVSCVS Health Corporation
01/05/202405:30PR Newswire (US)Northeast Indiana Greenlights Childcare Assistance for Working Families

Su Consulta Reciente

PM
XAUUSD
Gold vs US Dollar
NYSE
CVX
Chevron
COIN
SOLUSD
Solana
CCOM
US30
US 30
FX
USDMXN
US Dollar vs MXN
AMEX
XLE
Energy Select Sector SPDR
COIN
ETHUSD
Ethereum
SPI
SP500
S&P 500
NASDAQ
TSLA
Tesla
NYSE
KO
Coca Cola
AMEX
XLF
Financial Select Sector
NASDAQ
NVDA
NVIDIA
CCOM
US500
US 500
NYSE
AXP
American Express
USOTC
BNPQY
BNP Paribas (QX)
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados